Supplements > New Perspectives on Overactive Bladder: Quality of Life Impact, Medication Persistency, and Treatmen

Supplements - New Perspectives on Overactive Bladder: Quality of Life Impact, Medication Persistency, and Treatmen

July 15, 2005 – Eleanor M. Perfetto, PhD; Prasun Subedi, MS; and Zhanna Jumadilova, MD, MBA
July 15, 2005 – Zhanna Jumadilova, MD, MBA; Teresa Zyczynski, PharmD, MBA, MPH; Barbara Paul, MD; and Siva Narayanan, MS, MHS
July 15, 2005 – Sujata Varadharajan, MS; Zhanna Jumadilova, MD, MBA; Prafulla Girase, MS; and Daniel A. Ollendorf, MPH
July 15, 2005 – Nicole M. Nitz, PhD; Zhanna Jumadilova, MD, MBA; Theodore Darkow,   PharmD; Jennifer R. Frytak, PhD; and Tamara Bavendam, MD
July 15, 2005 – Richard G. Roberts, MD, JD; Alan D. Garely, MD; and Tamara Bavendam, MD
July 15, 2005 – Yu Ko, MS; Swu-Jane Lin, PhD; J. Warren Salmon, PhD; and Morgan S. Bron, PharmD, MS
July 15, 2005 – Fadia T. Shaya, PhD, MPH; Steven Blume, MS; Anna Gu, MA; Teresa Zyczynski, PharmD, MBA, MPH; and Zhanna Jumadilova, MD, MBA
July 15, 2005
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
×

Sign In

Not a member? Sign up now!